Selectivity between nonequivalent ortho sites of organoiridium-catalyzed deuterium exchange in meta-substituted substrates

ORGN 562

Charles S. Elmore, Chad.elmore@astrazeneca.com and J. Richard Heys. CNS Chemistry, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19850-5437
Catalyzed exchange of hydrogens for deuterium or tritium has become an increasingly important approach to the preparation of isotopically labeled compounds as a result of the development of new, efficient and regioselective catalytic systems. Among these, organoiridium complexes, such as [(cod)Ir(PPh3)2]BF4 and [(cod)Ir(PCy3)(py)]PF6, are frequently used for labeling of aryl derivatives possessing an appropriate iridium-coordinating function, which directs C-H activation to the ortho sites. Substrates possessing meta-substituents have nonequivalent ortho C-H bonds; however, little information is available about the influence meta-substituents have upon their selectivity. We have monitored the progress of organoiridium-catalyzed deuteration at the C2 and C6 positions in C3-substituted acetophenones and N,N-dimethylbenzamides by 1H NMR. There are marked differences in the rates of deuteration at the two sites. Non-coordinating C3-substituents retard C2 labeling relative to C6; however, coordinating substituents can counteract this effect, in some cases to the extent that C2-deuteration is favored over that at C6.